Factor H inhibits complement activation induced by liposomal and micellar drugs and the therapeutic antibody rituximab in vitro
Author:
Publisher
Elsevier BV
Subject
Pharmaceutical Science,General Materials Science,Biomedical Engineering,Molecular Medicine,Medicine (miscellaneous),Bioengineering
Reference43 articles.
1. Task force report: future research needs for the prevention and management of immune-mediated drug hypersensitivity reactions;Adkinson;J Allergy Clin Immunol,2002
2. Predictive capacity of histamine release for the diagnosis of drug allergy;Demoly;Allergy,1999
3. Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicals;Szebeni;Mol Immunol,2014
4. Complement and contrast material reactors;Lasser;J Allergy Clin Immunol,1979
5. Management and preparedness for infusion and hypersensitivity reactions;Lenz;Oncologist,2007
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exploring and Analyzing the Systemic Delivery Barriers for Nanoparticles;Advanced Functional Materials;2023-11-20
2. Nanoparticle-induced immune response: Health risk versus treatment opportunity?;Immunobiology;2023-03
3. Complement Factor H-Related Proteins FHR1 and FHR5 Interact With Extracellular Matrix Ligands, Reduce Factor H Regulatory Activity and Enhance Complement Activation;Frontiers in Immunology;2022-03-22
4. Combating Complement's Deleterious Effects on Nanomedicine by Conjugating Complement Regulatory Proteins to Nanoparticles;Advanced Materials;2022-01-11
5. Spotlight on the protein corona of liposomes;Acta Biomaterialia;2021-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3